Replacement of the ascending aorta for severe atherosclerosis during coronary artery bypass surgery
Ahmet Umit Gullu1, Eyup Murat Okten, Mehmet Hakan Akay
1Acibadem University, Department of Cardiovascular Surgery, Istanbul, Turkey. aumitgullu@yahoo.com
Insights
Ascending aorta replacement during coronary artery bypass surgery (CABG) is safe for patients with severe aortic atherosclerosis. This procedure offers good long-term outcomes, including reduced stroke rates post-discharge.
Area of Science:
- Cardiovascular Surgery
- Vascular Surgery
- Cardiac Surgery
Background:
- Severe aortic atherosclerosis poses risks during coronary artery bypass surgery (CABG).
- Ascending aorta replacement is a potential intervention for these high-risk patients.
Purpose of the Study:
- To investigate the benefits and outcomes of ascending aorta replacement in patients undergoing CABG for severe aortic atherosclerosis.
Main Methods:
- A retrospective study comparing 36 patients who underwent ascending aorta replacement during CABG with a control group of 3806 patients.
- Total circulatory arrest was utilized in 61% of the study group.
- Follow-up duration was 69 ± 36 months.
Main Results:
- The study group had higher baseline risk scores (mean additive Euroscore 9, logistic Euroscore 20).
- One early postoperative stroke (2.8%) occurred in the study group, with no strokes during the extended follow-up.
- Overall mortality in the study group was 12%, with causes including malignancy and cardiac issues.
Conclusions:
- Ascending aorta replacement can be safely performed in selected patients with severe aortic atherosclerosis undergoing CABG.
- The procedure demonstrates favorable long-term outcomes, including a low stroke incidence post-discharge.
Background And Aim:
In the present study, we investigated the benefit of ascending aorta replacement in patients with severe aortic atherosclerosis who undergo coronary artery bypass surgery (CABG).
Methods:
From January 2001 to April 2011, 3842 patients underwent CABG and in 36 of these patients (31 male, 5 female) the ascending aorta was replaced due to severe atherosclerosis. Total circulatory arrest was used in 22 patients (61%). The patients were followed for 69 ± 36 months (1-133 months) and compared to a control group of patients. The control group consisted of patients who underwent CABG with or without a concomitant procedure (n = 3806).
Results:
For the study group, the mean additive and logistic Euroscores of the patients were nine and 20, respectively. One stroke (2.8%) was observed and this patient died in the early postoperative period. There were a total of four confirmed deaths (12%) at any time point over the length of the follow-up among the patients who were discharged from the hospital. Two of them died of malignancy (lung and gastric tumors) and the other two from cardiac reasons. No patients had a stroke during follow-up. For the control group the mean age was 61 ± 1, the stroke rate was 0.6%, and the mortality rate was 0.96%, and the mean logistic and additive Euroscores were 3.7 ± 4.4, and 3.5 ± 2.5, respectively.
Conclusions:
Replacement of highly calcified ascending aortas during CABG can be safely performed in selected patients with good long-term outcomes.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care


